ArticleMolecular cell2026
DeorphaNN: Virtual screening of GPCR peptide agonists using AlphaFold-predicted active-state complexes and deep learning embeddings.
Article in Molecular cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Constitutively active orphan G protein-coupled receptors through the lenses of cryo-electron microscopy.The Journal of biological chemistry · 2025Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peptide-activated G protein-coupled receptors (GPCRs) regulate physiological processes through interaction with neuropeptides and peptide hormones. Identifying endogenous peptide agonists remains challenging, as peptide-GPCR pairings often follow gene-family relationships that offer limited predictive insight for orphan GPCRs without characterized homologs. Using a dataset of experimentally validated peptide-GPCR interactions from Caenorhabditis elegans, we demonstrate that AF-multimer confidence metrics partially discriminate agonist from non-agonist complexes, with improved discrimination using AF-Multistate-derived active-state templates. Feature analysis revealed that AF-multimer's pair representations outperform single representations, with distinct subregions providing complementary signals. Leveraging these insights, we developed DeorphaNN, a graph neural network integrating active-state GPCR-peptide structural predictions, interatomic interactions, and deep learning embeddings to prioritize putative peptide agonists for experimental screening. DeorphaNN generalized across diverse species, as shown by performance on annelid and human retrospective benchmarks. Experimental validation confirmed predicted agonists for two orphan GPCRs, demonstrating its utility for accelerating peptide-GPCR deorphanization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.